Ken Griffin Neuro Sense Therapeutics Ltd. Call Options Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NRSN
# of Institutions
8Shares Held
225KCall Options Held
0Put Options Held
0-
Cantor Fitzgerald, L. P. New York, NY79.5KShares$95,3900.01% of portfolio
-
Xtx Topco LTD London, X046KShares$55,1950.0% of portfolio
-
Meitav Dash Investments LTD40KShares$48,0000.0% of portfolio
-
Commonwealth Equity Services, LLC12.6KShares$15,1500.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12KShares$14,3550.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $14M